VOR and PRTC Related Headlines
Go Back- PureTech Health plc – Half-Year Report
- PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement
VOR and PRTC Related Press Releases
Go Back- PureTech Health plc – Half-Year Report
- PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

